In July 2023, at the second Russia-Africa Summit, held in St. Petersburg, the event was predominantly seen as a reflection of ...

Zermelo-Fraenkel set theory is so widely accepted that modern mathematicians hardly think about it. But believing in its core principles didn’t come easily. How do mathematicians decide that something ...

An interferon-stimulated genes signature including IFI27 and OAS1, together with complement levels, may reflect the immune state of patients with SLE and identify active disease. An automated ...

Quantum computers—devices that process information using quantum mechanical effects—have long been expected to outperform classical systems on certain tasks. Over the past few decades, researchers ...

Descriptive set theorists study the niche mathematics of infinity. Now, they’ve shown that their problems can be rewritten in the concrete language of algorithms. All of modern mathematics is built on ...

For the past several years, America has been using its young people as lab rats in a sweeping, if not exactly thought-out, education experiment. Schools across the country have been lowering standards ...

In a recent study, mathematicians from Freie Universität Berlin have demonstrated that planar tiling, or tessellation, is much more than a way to create a pretty pattern. Consisting of a surface ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Michael Sullivan Michael Sullivan is a writer covering kitchen equipment and ...

With future approvals of FABHALTA, the market size is expected to expand significantly in the coming years, driven by its potential to address unmet medical needs across multiple conditions like IgAN, ...

Iptacopan is an innovative, first-in-class oral small molecule that reversibly inhibits factor B—a crucial serine protease in the alternative pathway of the complement system. By targeting this point ...

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...